SAN DIEGO, July 7, 2016 /PRNewswire/ -- ResMed Inc. (NYSE: RMD) today announced it will report its fourth quarter of fiscal year 2016 results on Thursday, July 28, 2016 after the New York Stock Exchange market closes. A press release with ResMed's results will be issued after 1:00 p.m. US Pacific Time and the company will host a webcast to discuss operating results and future outlook.
The earnings webcast is scheduled to begin at 1:30 p.m. US Pacific Time and the live webcast of the call can be accessed on ResMed's Investor Relations website at investors.resmed.com. Please go to this section of the website and click on the icon for the "Q4 2016 earnings webcast."
Please note that we do not use outside conference lines to access the earnings call.
International earnings webcast times will be:
9:30 p.m. London
6:30 a.m. Sydney, Australia (July 29, 2016)
A replay of the earnings webcast will be accessible on our website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately two hours after the webcast and will be accessible from July 28, 2016 until August 11, 2016 at:
US: 855-859-2056 Outside US: +1 404-537-3406 Passcode: 45507665
About ResMed
ResMed (NYSE:RMD) changes lives with award-winning medical devices and cutting-edge cloud-based software applications that better diagnose, treat and manage sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed is a global leader in connected care, with more than 2 million patients remotely monitored every day. Our 5,000-strong team is committed to creating the world's best tech-driven medical device company – improving quality of life, reducing the impact of chronic disease, and saving healthcare costs in more than 100 countries.
ResMed.com | Facebook | Twitter | LinkedIn
Logo - http://photos.prnewswire.com/prnh/20140310/LA79234LOGO-a
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/resmed-to-announce-fourth-quarter-fiscal-year-2016-results-300295000.html
SOURCE ResMed Inc.